Role of eicosanoids in the pathogenesis of murine cerebral malaria

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 4, 1999, Pages 668-673

  Xiao, Lihua ^a   Patterson, Pamela S ^a   Yang, Chunfu ^a   Lal, Altaf A ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ICOSANOID; LEUKOTRIENE; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; ICOSANOID METABOLISM; MOUSE; NEUROPROTECTION; NONHUMAN; PLASMODIUM BERGHEI; PROTEIN EXPRESSION;

EID: 0032926162     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.668     Document Type: Article

References (27)

1. Aikawa M, 1988. Human cerebral malaria. Am J Trop Med Hyg 39: 3-10.
2. Boonpucknavig V, Boonpucknavig S, Udomsangpetch R, Nitiyanant P, 1990. An immunofluorescence study of cerebral malaria: a correlation with histopathology. Arch Pathol Lab Med 114: 1028-1034.
3. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA, 1985. Human cerebral malaria: a quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol 119: 385-401.
4. Nagatake T, Thuc HV, Tegoshi T, Rabbege J, Ann TK, Aikawa M, 1992. Pathology of human cerebral malaria in Vietnam. Am J Trop Med Hyg 47: 259-264.
5. Porta J, Carota A, Pizzolato GP, Wildi E, Widmer MC, Margairaz C, Grau GE, 1993. Immunopathological changes in human cerebral malaria. Clin Neuropathol 12: 142-146.
6. Sein KK, Maeno Y, Thuc HV, Anh TK, Aikawa M, 1993. Differential sequestration pattern of parasitized erythrocytes in the cerebrum and cerebellum in human cerebral malaria. Am J Trop Med Hyg 48: 504-511.
7. Sein KK, Brown AE, Maeno Y, Smith CD, Corcoran KD, Hansukjariya P, Webster HK, Aikawa M, 1993. Sequestration pattern of parasitized erythrocytes in cerebrum, mid-brain, and cerebellum of Plasmodium coatneyi-infected rhesus monkeys (Macaca mulatta). Am J Trop Med Hyg 49: 513-519.
8. Neill AL, Hunt NH, 1992. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 105: 165-175.
9. Curfs JHAJ, Van der Meide PH, Billiau A, Meuwissen JHETh, Eling WMC, 1993. Plasmodium berghei: recombinant interferon-γ and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp Parasitol 77: 212-223.
10. de Kossodo S, Grau GE, 1993. Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol 151: 4811-4820.
11. Rudin W, Eugster H-P, Bordmann G, Bonato J, Muller M, Yamage M, Ryffel B, 1997. Resistance to cerebral malaria in tumor necrosis factor-α/β-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am J Pathol 150: 257-266.
12. Clark IA, Rockett KA, Cowden WB, 1991. Proposed link between cytokines, nitric oxide, and human cerebral malaria. Parasitol Today 7: 205-207.
13. Grau GE, Bieler G, Pointaire P, de Kossodo S, Tacchini-Cotier F, Vassalli P, Piguet PF, Lambert P-H, 1990. Significance of cytokine production and adhesion molecules in malarial immunopathology. Immunol Lett 25: 189-194.
14. Grau GE, Lou JN, 1995. Experimental cerebral malaria: possible new mechanisms in the TNF-induced microvascular pathology. Soz Praventivmed 40: 50-57.
15. Gerritsen ME, 1996. Physiological and pathophysiological roles of eicosanoids in microcirculation. Cardiovasc Res 32: 720-732.
16. Vadas P, Keystone J, Stefanski E, Scott K, Pruzanski W, 1992. Induction of circulating group II phospholipase A2 expression in adults with malaria. Infect Immun 60: 3928-3931.
17. Vadas P, Taylor TE, Chimsuku L, Goldring D, Stefanski E, Pruzanski W, Molyneux ME, 1993. Increased serum phospholipase A2 activity in Malawian children with falciparum malaria. Am J Trop Med Hyg 49: 455-459.
18. Clark IA, Hunt NH, 1986. Increased production of arachidonate metabolites by peritoneal cells of mice infected with Plasmodium vinckei vinckei. Aust J Exp Biol Med Sci 64: 415-418.
19. Ahvazi BC, Jacobs P, Stevenson MM, 1995. Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria. J Leukoc Biol 58: 23-31.
20. Riley EM, MacLennan C, Wiatkowski DK, Greenwood BM, 1989. Suppression of in-vitro lymphoproliferative responses in acute malaria patients can be partially reversed by indomethacin. Parasite Immunol 11: 509-517.
21. Weston MJ, Jackman N, Rudge C, Bowles J, Brady C, Bielawska C, O'Grady J, 1982. Prostacyclin in falciparum malaria. Lancet 2: 609.
22. Sliwa K, Grundmann HJ, Neifer S, Chaves MF, Sahlmuller G, Blitstein-Willinger E, Bienzle U, Kremsner PG, 1991. Prevention of murine cerebral malaria by a stable prostacyclin analog. Infect Immun 59: 3846-3848.
23. Green MD, Xiao L, Lal AA, 1996. Formation of hydroxyeicos-atetraenoic acids from hemozoin-catalyzed oxidation of arachidonic acid. Mol Biochem Parasitol 83: 183-188.
24. Xiao L, Yang C, Nelson CO, Holloway BP, Udhayakumar V, Lal AA, 1996. Quantitation of RT-PCR amplified cytokine mRNA by aequorin-based bioluminescence immunoassay. J Immunol Methods 199: 139-147.
25. Peplow PV, 1996. Action of cytokines in relation to arachidonic acid metabolism and eicosanoid production. Prostaglandins Leukot Essent Fatty Acids 54: 303-317.
26. Blok WL, Vogels MT, Curfs JH, Eling WM, Buurman WA, van der Meer JW, 1992. Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice. J Infect Dis 165: 898-903.
27. English M, Marsh V, Amukoye E, Lowe B, Murphy A, Marsh K, 1996. Chronic salicylate poisoning and severe malaria. Lancet 347: 1736-1737.